Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000214365 | SCV000273389 | likely benign | Hereditary cancer-predisposing syndrome | 2015-01-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV004020646 | SCV000647237 | likely benign | Familial adenomatous polyposis 1 | 2024-01-24 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000214365 | SCV000686892 | likely benign | Hereditary cancer-predisposing syndrome | 2017-09-11 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000600698 | SCV000716569 | likely benign | not provided | 2020-02-19 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV001800542 | SCV002047101 | likely benign | not specified | 2021-05-14 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV004020646 | SCV004931806 | benign | Familial adenomatous polyposis 1 | 2024-03-12 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |